Diadia
Our TechnologyResourcesAboutLoginBook a call

© 2026 Diadia. All rights reserved.

About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions
About UsOur TechnologyResearchResources
Privacy Policy
SupportBook a callLogin
Health Privacy Policy
InstagramFacebookLinkedInX (formerly Twitter)
Terms and Conditions

© 2026 Diadia. All rights reserved.

←Transparency Reports

metabolic · Mechanism Report

Is the LEPR rs1137101 GG genotype associated with adiposity and weaker sleep-related respiratory compensation?

The LEPR rs1137101 GG genotype may modestly increase susceptibility to adiposity, but a GG-specific leptin-resistance defect is not established.

PlausibleSeptember 14, 20268 Sources

Reasoning Paths

Each route from condition to outcome carries a support score — the product of its edge weights. Select one to isolate it on the figure.

This is what AI claimed

The LEPR rs1137101 GG genotype is associated with greater susceptibility to leptin resistance and adiposity, while impaired leptin signaling can weaken compensatory respiratory stimulation during sleep.

laying out figure…
2 of 5 paths supported
UnsupportedPlausibleSupported

How to read the figure

Evidence state

  • ●EstablishedStrong, replicated evidence.
  • ◐ModerateEvidence-informed; limited or moderate.
  • ◇PlausibleMechanistically coherent, not established.
  • ✕UnsupportedTested and not supported — link breaks.
  • ?MissingNo evidence either way — untested.

Node shapes

  • BiomarkerA measurable state — a lab value, hormone, or genetic factor.
  • ProcessA biological process, pathway, or mechanism step.
  • ConditionA condition, exposure, intervention, or symptom.
  • OutcomeThe endpoint the claim leads to.

Executive summary

The claim links the LEPR rs1137101 GG genotype to greater adiposity susceptibility and to a possible tendency toward leptin resistance. The mechanism framing supports a role for impaired leptin signaling in reducing compensatory breathing during sleep, with downstream effects such as hypoventilation and airway collapsibility. However, the genotype-to-leptin-resistance part remains uncertain.

Verified conclusion

At age 57, this genetic finding should be interpreted as a modest risk modifier rather than a diagnosis or explanation for sleep-related breathing symptoms. The strongest evidence separates an obesity-susceptibility association from an unproven GG-specific defect in leptin signaling.

Genetic and adiposity evidence

  • LEPR rs1137101 GG (Q223R Arg/Arg) was associated with obesity in a 2024 meta-analysis of 39 case-control studies (6,099 cases; 6,711 controls): OR 1.39 versus AA (95% CI 1.12–1.73).
  • The association was heterogeneous (I²=63%), stronger in Asian populations and not statistically significant in Caucasian populations. Earlier pooled evidence was null overall (OR 1.05, 95% CI 0.92–1.21).
  • Thus, GG may modestly increase susceptibility to adiposity in some populations, but it is not determinative and does not establish an independent association with obstructive sleep apnea.

Leptin-resistance interpretation

  • Q223R alters the extracellular LEPR domain, creating a biologically plausible hypothesis of altered receptor behavior.
  • Direct functional studies found no meaningful differences in leptin-induced STAT3 signaling or transcription, and humanized mice showed no differences in adiposity, energy expenditure, or metabolic response. A GG-specific predisposition to leptin resistance therefore remains uncertain.

Respiratory mechanisms

  • Impaired leptin signaling can weaken compensatory sleep ventilation, especially the hypercapnic (CO₂-driven) response. Leptin-deficient mice have lower sleep ventilation and markedly blunted CO₂ responsiveness; leptin replacement restores these effects independent of weight.
  • Leptin deficiency/resistance also promotes sleep-related hypoventilation and pharyngeal collapsibility in animal models. Relevant pathways include hypothalamic, medullary/retrotrapezoid, carotid-body, and respiratory motor-control circuits.
  • In 186 humans, higher leptin correlated independently with lower hypercapnic drive, but this does not prove causation because leptin strongly tracks adiposity and sleep apnea-related mechanics.

Bottom line

  • GG plausibly contributes to adiposity susceptibility, but not established leptin resistance. Impaired leptin signaling has a supported mechanistic role in reduced CO₂-compensatory breathing during sleep; whether this genotype causes that impairment in an individual remains unproven.

References

  1. Functional consequences of the human leptin receptor (LEPR ... — pmc.ncbi.nlm.nih.gov ↗
  2. Association of the leptin receptor Q223R (rs1137101 ... - PMC — pmc.ncbi.nlm.nih.gov ↗
  3. Meta-analysis investigating the impact of the LEPR ... — pmc.ncbi.nlm.nih.gov ↗
  4. The effect of leptin replacement on sleep-disordered breathing in the leptin-deficient ob/ob mouse — pmc.ncbi.nlm.nih.gov ↗
  5. Central leptin replacement enhances chemorespiratory responses in leptin-deficient mice independent of changes in body weight — pmc.ncbi.nlm.nih.gov ↗
  6. Impact of interrupted leptin pathways on ventilatory control | Journal of Applied Physiology | American Physiological Society — journals.physiology.org ↗
  7. Hyperleptinaemia, respiratory drive and hypercapnic ... — publications.ersnet.org ↗
  8. Intranasal Leptin Relieves Sleep-disordered Breathing in Mice ... — pmc.ncbi.nlm.nih.gov ↗

See a full patient report verified like this

Book a walkthrough

Related Claims

Plausible8 sourcesDoes the MTHFR rs1801131 A1298C variant mildly reduce enzyme activity and have a smaller homocysteine effect than C677T?→Plausible3 sourcesIs TMAO formed from gut microbial conversion of choline and carnitine followed by liver oxidation?→